Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol. Academic Article uri icon

start page

  • 126

end page

  • 134

abstract

  • Data from a published double-blind randomized trial comparing olanzapine versus haloperidol in acute mania were used to address the response and tolerability of Latin American patients. Primary efficacy end point was the remission rate (Young Mania Rating Scale score

date/time value

  • April 2007

Digital Object Identifier (DOI)

  • 10.1097/JCP.0b013e318033bd4a

PubMed Identifier

  • 17414234

volume

  • 27

number

  • 2

keywords

  • Acute Disease
  • Aged
  • Antipsychotic Agents
  • Benzodiazepines
  • Bipolar Disorder
  • Cholesterol
  • Diagnostic and Statistical Manual of Mental Disorders
  • Double-Blind Method
  • European Continental Ancestry Group
  • Fasting
  • Female
  • Haloperidol
  • Hispanic Americans
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Time Factors
  • Treatment Outcome
  • Weight Gain